Department of Orthopedics, Fujian Provincial Institute of Orthopedics, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Department of Pharmacy, Longyan First Hospital, Affiliated to Fujian Medical University, Longyan 364000, China.
Anal Chem. 2021 Jan 19;93(2):911-919. doi: 10.1021/acs.analchem.0c03563. Epub 2020 Dec 7.
Accurate and sensitive detection of single-base mutations in RNAs is of great value in basic studies of life science and medical diagnostics. However, the current available RNA detection methods are challenged by heterogeneous clinical samples in which trace RNA mutants usually existed in a large pool of normal wild sequences. Thus, there is still great need for developing the highly sensitive and highly specific methods in detecting single-base mutations of RNAs in heterogeneous clinical samples. In the present study, a new chimeric DNA probe-aided ligase chain reaction-based electrochemical method (cmDNA-eLCR) was developed for RNA mutation detection through the BSA-based carrier platform and the horseradish peroxidase-hydrogen peroxide-tetramethylbenzidine (HRP-HO-TMB) system. The denaturing polyacrylamide gel electrophoresis and a fluorophore-labeled probe was ingeniously designed to demonstrate the advantage of cmDNA in ligation to normal DNA templated by RNA with the catalysis of T4 RNA ligase 2 as well as its higher selectivity than DNA ligase system. Finally, the proposed cmDNA-eLCR, compared with the traditional eLCR, showed excellent performance in discriminating single base-mismatched sequences, where the signal response for mismatched targets at a high concentration could overlap completely with that for the blank control. Besides, this cmDNA-eLCR assay had a wide linear range crossing six orders of magnitude from 1.0 × 10 to1.0 × 10 M with a limit of detection as low as 0.6 fM. Furthermore, this assay was applied to detect RNA in real sample with a satisfactory result, thereby demonstrating its great potential in diagnosis of RNA-related diseases.
准确而灵敏地检测 RNA 中的单碱基突变对于生命科学基础研究和医学诊断具有重要价值。然而,目前可用的 RNA 检测方法在痕量 RNA 突变体通常存在于大量正常野生序列的异质临床样本中时受到挑战。因此,仍然需要开发用于在异质临床样本中检测 RNA 单碱基突变的高灵敏度和高特异性方法。在本研究中,通过基于 BSA 的载体平台和辣根过氧化物酶-过氧化氢-四甲基联苯胺(HRP-HO-TMB)系统,开发了一种新的嵌合 DNA 探针辅助连接酶链反应电化学方法(cmDNA-eLCR)用于 RNA 突变检测。变性聚丙烯酰胺凝胶电泳和荧光标记探针的巧妙设计证明了 cmDNA 在 T4 RNA 连接酶 2 催化下与 RNA 模板正常 DNA 连接的优势,以及其比 DNA 连接酶系统更高的选择性。最后,与传统的 eLCR 相比,所提出的 cmDNA-eLCR 在区分单碱基错配序列方面表现出优异的性能,其中高浓度错配靶标信号响应可以与空白对照完全重叠。此外,该 cmDNA-eLCR 测定法具有跨越六个数量级的从 1.0×10 到 1.0×10 M 的宽线性范围,检测限低至 0.6 fM。此外,该测定法已应用于真实样本中 RNA 的检测,取得了令人满意的结果,从而证明了其在 RNA 相关疾病诊断中的巨大潜力。